FIELD: chemistry.
SUBSTANCE: invention relates to a trinucleotide capping reagent of formula
,
where R is H or Me, or a salt thereof, suitable for a transcription reaction, as well as to a complex for cotranscriptional capping of mRNA, a method for production thereof and use of a trinucleotide capping reagent for cotranscriptional capping of mRNA.
EFFECT: novel trinucleotide capping reagent is obtained, which is incorporated into the mRNA structure cotranscriptionally and provides improved efficiency of mRNA translation.
5 cl, 3 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| mRNA-BASED VECTOR FOR INCREASED TARGET PROTEIN PRODUCTION IN MAMMALIAN CELLS (VARIANTS) | 2022 |
|
RU2792231C1 |
| mRNA-BASED IMMUNOBIOLOGICAL AGENT FOR PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 2024 |
|
RU2823754C1 |
| METHODS AND MEANS OF INCREASING PRODUCTIVITY OF RNA | 2015 |
|
RU2738753C2 |
| PLASMID pVAX-RBD DNA MATRIX OF mRNA-RBD MOLECULES, OBTAINED USING THE pVAX - RBD DNA MATRIX, PROVIDING THE SYNTHESIS AND SECRETION OF THE RBD PROTEIN SARS-CoV 2 IN MAMMALIAN CELLS AND A COMPLEX IN THE FORM OF NANOPARTICLES CONTAINING mRNA-RBD MOLECULES THAT INDUCE SARS-CoV-SPECIFIC ANTIBODIES WITH VIRAL NEUTRALIZING ACTIVITY | 2021 |
|
RU2754230C1 |
| 5'-CAP-TRINUCLEOTIDE COMPOUNDS OR 5'-CAP COMPOUNDS WITH LARGE NUMBER OF NUCLEOTIDES AND THEIR USE FOR RNA STABILIZATION, PROTEIN EXPRESSION AND IN THERAPY | 2019 |
|
RU2811940C2 |
| MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND USE THEREOF | 2012 |
|
RU2707251C2 |
| METHOD FOR FORMING IMMUNE SURVEILLANCE SYSTEM FOR TUMOUR CELLS IN MAMMAL BODY | 2024 |
|
RU2828654C1 |
| SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
| MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND THEIR APPLICATION | 2012 |
|
RU2648950C2 |
| USE OF 6-FLUORO-3-TRIAZENONE INDOLES FOR THERAPY OF INFECTIONS CAUSED BY MRSA | 2019 |
|
RU2712265C1 |
